SERUM LIPID PROFILE AND ITS ASSOCIATION WITH HYPERTENSION IN INDIA–A CROSS-SECTIONAL STUDY
Main Article Content
Keywords
Hypertension; Lipid profile; Dyslipidaemia; LDL-cholesterol; Triglycerides; Indianadults; Community screening.
Abstract
Background
Hypertension is widely encountered in Indian outpatient practice, often appearing alongside othermetabolic disturbances that go unnoticed for several years. Lipid abnormalities are among the mostfrequent of these accompanying changes, yet their relationship with hypertension in communitysettings is not always clear, especially when individuals seek care irregularly or undergo testing onlyduring screening drives.
Objective
To examine how fasting lipid parameters vary between hypertensive and normotensive adults in anIndian community sample, and to explore whether specific lipid markers show stronger associationswith elevated blood pressure.
Methods
This cross-sectional study included 260 adults recruited from community screening camps and routineoutpatient visits. Blood pressure was measured using standard procedures, and hypertension wasdefined as systolic ≥140 mmHg or diastolic ≥90 mmHg. Fastinglipid profiles were obtained throughenzymatic assays. Associations between lipid markers and hypertension were analysed using t-tests,chi-square tests, and subgroup comparisons across age, sex, and BMI.
Results
Hypertension was present in a little over one-third of participants. Mean total cholesterol, LDL-cholesterol, and triglyceride levels were noticeably higher among hypertensive adults, while HDL-cholesterol tended to be lower. These differences were most apparent in middle-aged and overweightgroups. The proportion of participants with dyslipidaemia was also significantly higherin thehypertensive category (p<0.001). LDL-cholesterol showed the strongest association withhypertension, followed by triglycerides.
Conclusion
In this community sample, lipid abnormalities were more frequent and more pronounced among adultswith hypertension. The pattern suggests a shared metabolic pathway that may begin earlier than overtdisease. Incorporating routine lipid assessment into community blood pressure screening may helpidentify individuals at higher cardiometabolic risk in India.
References
India. Indian Heart J2018;70(4):565–72.
[2]Gordon T, Castelli WP, Hjortland MC,et al. High density lipoprotein as a protective factor against
coronary heart disease.The Framingham Study. Am J Med1977;62(5):707–14.
[3]Joshi SR, Anjana RM, Deepa M, et al.Prevalence of dyslipidemia in urban and rural India: The
ICMR–INDIAB Study. PLoS One2014;9(5):e96808.
[4]Chaturvedi V, Ramakrishnan L, Gupta N, et al.Blood pressure and hypertension epidemiology
in India: An analysis from the National Family Health Survey-5. J Hum Hypertens2022;36(5):434–42.
[5]Gupta R, Gaur K,Ram CVS.Emerging trends in hypertension epidemiology in India. J Hum
Hypertens2019;33(8):575–87.
[6]Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of
premature death from coronary heart disease continuous and graded? Findings in356,222primary screenees. JAMA1986;256(20):2823–8.
[7]Tall AR, Rader DJ. The trials and tribulations of CETP inhibitors. Circ Res. 2018;122(1):106–12.
[8]Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC multisociety cholesterol guideline. J
Am Coll Cardiol2019;73(24):e285–350.
[9]Anchala R, Kannuri NK, Pant H, et al.Hypertension in India: A systematic review and meta-
analysis of prevalence, awareness, and control. J Hypertens 2014;32(6):1170-7.
[10]Zanchetti A, Thomopoulos C, Parati G. Randomized controlled trials of combined lipid and blood
pressure treatment: Evidence and implications. Eur Heart J 2015;36(6):365-75.
[11]Mendis S, Puska P, Norrving B, eds. Globalatlas on cardiovascular disease prevention and
control. Geneva: World Health Organization2011.

